Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Oropharyngeal cancer
Stage/Subtype:  stage II oropharyngeal cancer
Country:  U.S.A.
Trial Type:  Treatment
Results 1-15 of 15 for your search:
Start Over
Intensity-Modulated Proton Beam Therapy or Intensity-Modulated Photon Therapy in Treating Patients with Stage III-IVB Oropharyngeal Cancer
Status: Active
Phase: Phase III, Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 2012-0825, NCI-2013-01879, NCT01893307
Vaccine Therapy and Cyclophosphamide in Treating Patients with Pancreatic Cancer
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: J09100, NCI-2010-01868, CIR00005394, NA_00031401, NCT01088789
Docetaxel, Cisplatin, and Cetuximab in Treating Patients with Metastatic or Relapsed Head and Neck Cancer
Status: Active
Phase: Phase II
Type: Treatment
Age: 16 and over
Trial IDs: ENT0033, NCI-2011-03271, 22329, SU-08222011-8290, NCT01437449
Azacitidine in Measuring Tumor Response in Patients with HPV Positive or Negative Head and Neck Squamous Cell Carcinoma That Can Be Removed by Surgery
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 1404013771, NCI-2015-01437, NCT02178072
Transoral Robotic Surgery and Adjuvant Therapy in Treating Patients with HPV-Positive Oropharyngeal Cancer That Can Be Removed by Surgery
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 2013-0925, NCI-2014-02126, NCT02225496
Intensity-Modulated Radiation Therapy and Chemotherapy in Treating Patients with Low-Risk HPV-Related Oropharyngeal Squamous Cell Carcinoma
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: LCCC 1413, NCI-2014-02348, 14-1795, NCT02281955
Surgery with or without Stereotactic Body Radiotherapy in Treating Patients with Previously-Irradiated Head and Neck Cancer
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 14-151, NCI-2015-01424, NCT02516969
Pembrolizumab, Cisplatin, and Intensity Modulated Radiation Therapy in Treating Patients with Previously Untreated Stage III-IVb Head and Neck Cancer
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: UPCI 15-132, NCI-2016-00793, NCT02777385
Neck Dissection-Stratified Treatment in Improving Quality of Life in Patients with Low Risk HPV-Positive Oropharyngeal Cancer
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: UMCC 2015.126, NCI-2016-01063, NCT02784288
Afatinib Dimaleate and Radiation Therapy with or without Docetaxel in Treating Patients with Head and Neck Cancer Previously Treated with Surgery
Status: Active
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: 12-267, NCI-2013-00626, NCT01783587
Biomarker Response to Cetuximab and VTX-2337 in Treating Patients with Stage II-IVA Head and Neck Cancer
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 14-002, NCI-2014-01430, UPCI #14-002, VRXP-A106, NCT02124850
Image-Guided Hypofractionated Intensity Modulated Radiation Therapy and Cisplatin in Treating Patients with Locally Advanced Squamous Cell Carcinoma of the Oropharynx, Hypopharynx, or Larynx
Status: Active
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: STU 112013-007, NCI-2014-02123, 8843, NCI-2014-02009, NCT02201355
Transoral Robotic Surgery in Treating Patients with Oropharyngeal or Supraglottic Squamous Cell Carcinoma
Status: Active
Phase: No phase specified
Type: Supportive care, Treatment
Age: 18 and over
Trial IDs: SCCA-TORS-2012, NCI-2013-01936, 16376, NCT01819480
Body Warming in Improving Blood Flow and Oxygen Delivery to Tumors in Patients with Cancer
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: I 229812, NCI-2013-01198, NCT01896778
Transoral Robotic Surgery in Treating Patients With Oropharyngeal, Hypopharyngeal, and Oral Cavity Cancer
Status: Active
Phase: No phase specified
Type: Treatment
Age: 20 and over
Trial IDs: HNO 0601, NCI-2011-03028, NCT00473564
Start Over